These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15332584)

  • 1. [Blockers of angiotensin receptors: a novel approach to the treatment of secondary pulmonary hypertension].
    Butorov IV; Verbitskiĭ ON; Butorov SI
    Ter Arkh; 2004; 76(6):84-7. PubMed ID: 15332584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of losartan treatment of right ventricular cardiac insufficiency in patients with chronic obstructive bronchitis].
    Butorov IV; Verbitskiĭ ON; Butorov SI; Paraska VI
    Klin Med (Mosk); 2003; 81(7):48-51. PubMed ID: 12934312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficiency of perstarium in the treatment of patients with chronic obstructive bronchitis and pulmonary hypertension].
    Buturov IV; Buturov SI; Verbitskiĭ ON; Guzun RG; Paraska VI
    Probl Tuberk Bolezn Legk; 2003; (11):26-9. PubMed ID: 14689794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new approach to treating secondary pulmonary hypertension].
    Butorov IV; Verbitskiĭ ON; Butorov SI
    Probl Tuberk Bolezn Legk; 2005; (9):33-6; discussion 36. PubMed ID: 16279515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of lozartan in patients with chronic cor pulmonale].
    Butorov IV; Butorov SI
    Klin Med (Mosk); 2005; 83(7):65-9. PubMed ID: 16117431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
    Krupicka J; Ceypová K; Kristenová P; Hauser T
    Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and hemodynamical efficacy of prestarium and its role in the treatment of chronic pulmonary heart].
    Korneĭchuk NN; Butorov IV; Verbitskiĭ ON; Butorova VG; Paraska VI
    Ter Arkh; 2003; 75(10):83-7. PubMed ID: 14669615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
    Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
    J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of a cardioselective beta1-adrenoblocker bisoprolol in patients with chronic obstructive pulmonary disease in combination with ischemic heart disease].
    Tsvetkova OA; Veselovskaia MV
    Ter Arkh; 2007; 79(3):25-9. PubMed ID: 17526191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Losartan improves heart rate variability and heart rate turbulence in heart failure due to ischemic cardiomyopathy.
    Ozdemir M; Arslan U; Türkoğlu S; Balcioğlu S; Cengel A
    J Card Fail; 2007 Dec; 13(10):812-7. PubMed ID: 18068613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
    Sookoian S; Castaño G; García SI; Viudez P; González C; Pirola CJ
    Am J Gastroenterol; 2005 Mar; 100(3):636-42. PubMed ID: 15743363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
    Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
    Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of the angiotensin II receptor antagonist losartan in patients with portal hypertensive gastropathy.
    Wagatsuma Y; Naritaka Y; Shimakawa T; Kanako H; Keiichiro I; Shunichi S; Konno S; Katsube T; Ogawa K
    Hepatogastroenterology; 2006; 53(68):171-4. PubMed ID: 16608017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of blood pressure control on cardiovascular events in 26,512 Japanese hypertensive patients: the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
    Shimamoto K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimada K; Tanaka H; Yoshiike N;
    Hypertens Res; 2008 Mar; 31(3):469-78. PubMed ID: 18497466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
    Schjoedt KJ; Lajer M; Andersen S; Tarnow L; Rossing P; Parving HH
    Scand J Clin Lab Invest; 2006; 66(3):173-80. PubMed ID: 16714246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of losartan, lisinopril and their combination on hemodynamics and morphofunctional parameters of the heart in patients with chronic cardiac failure].
    Tofan EF; Butorov IV; Gonchar VI; Nekula GI
    Klin Med (Mosk); 2011; 89(1):40-4. PubMed ID: 21516765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
    Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
    Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.